...
首页> 外文期刊>Nutrition Research >Mango polyphenolics suppressed tumor growth in breast cancer xenografts in mice: role of the PI3K/AKT pathway and associated microRNAs
【24h】

Mango polyphenolics suppressed tumor growth in breast cancer xenografts in mice: role of the PI3K/AKT pathway and associated microRNAs

机译:芒果多酚类药物抑制小鼠乳腺癌异种移植物中肿瘤的生长:PI3K / AKT途径和相关microRNA的作用

获取原文
获取原文并翻译 | 示例
           

摘要

The cytotoxic and anti-inflammatory properties of mango polyphenolics including gallic acid and gallotannins have been demonstrated in numerous types of cancers. We hypothesized that the phosphoinositide 3-kinase (PI3K)/AKT pathway and the expression of related miRNAs are involved in the chemotherapeutic activities of mango polyphenolics in a mouse xenograft model for breast cancer. The objectives of this research were to determine the tumor-cytotoxic activities of mango polyphenolics and the underlying molecular mechanisms involving posttranscriptional targets in BT474 breast cancer cells and xenografts in mice. In vitro findings showed cytotoxic effects of mango polyphenolics in BT474 breast cancer cells within a concentration range of 2.5 to 20 mg/L gallic acid equivalents. Mango polyphenolics suppressed the expression of PI3K, AKT, hypoxia inducible factor-1 alpha, and vascular endothelial growth factor (VEGF) mRNA, and pAKT, AKT, pPI3K (p85), VEGF and nuclear factor kappa B protein levels. The involvement of miR-126 was verified by using antagomiR for miR-126, where mango reversed the effect of the antagomiR of miR-126. In vivo, the intake of mango polyphenolics decreased the tumor volume by 73% in BT474 xenograft-bearing mice compared with the control group. In addition, mango reduced the expression of nuclear factor kappa B (p65), pAKT, pPI3K, mammalian target of rapamycin, hypoxia inducible factor-1a, and VEGF protein in athymic nude mice. A screening for miRNA expression changes confirmed that mango polyphenolics modulated the expression of cancer-associated miRNAs including miR-126 in the xenografted tumors. In summary, mango polyphenolics have a chemotherapeutic potential against breast cancer that at least in part is mediated through the PI3K/AKT pathway and miR-126. (C) 2015 Elsevier Inc. All rights reserved.
机译:芒果多酚类化合物(包括没食子酸和没食子单宁)的细胞毒性和抗炎特性已在多种癌症中得到证实。我们假设磷酸肌醇3-激酶(PI3K)/ AKT途径和相关miRNA的表达参与乳腺癌小鼠异种移植模型中芒果多酚类化合物的化学治疗活性。这项研究的目的是确定芒果多酚类化合物的肿瘤细胞毒性活性以及涉及BT474乳腺癌细胞和小鼠异种移植物中转录后靶标的潜在分子机制。体外研究结果表明,芒果多酚类化合物在浓度为2.5至20 mg / L没食子酸当量的BT474乳腺癌细胞中具有细胞毒性作用。芒果多酚抑制PI3K,AKT,缺氧诱导因子-1α和血管内皮生长因子(VEGF)mRNA以及pAKT,AKT,pPI3K(p85),VEGF和核因子kappa B蛋白水平的表达。通过将antagomiR用于miR-126验证了miR-126的参与,其中芒果逆转了miR-126的antagomiR的作用。在体内,与对照组相比,摄取芒果多酚类药物的BT474异种移植小鼠的肿瘤体积减少了73%。此外,芒果降低了无胸腺裸鼠中核因子κB(p65),pAKT,pPI3K,哺乳动物雷帕霉素靶标,低氧诱导因子-1a和VEGF蛋白的表达。对miRNA表达变化的筛查证实,芒果多酚可调节异种移植肿瘤中与癌症相关的miRNA(包括miR-126)的表达。总之,芒果多酚类化合物具有抗乳腺癌的化学治疗潜力,至少部分是通过PI3K / AKT途径和miR-126介导的。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号